DK200100959A - Fremgangsmåde til fremstilling af citalopram - Google Patents

Fremgangsmåde til fremstilling af citalopram Download PDF

Info

Publication number
DK200100959A
DK200100959A DK200100959A DKPA200100959A DK200100959A DK 200100959 A DK200100959 A DK 200100959A DK 200100959 A DK200100959 A DK 200100959A DK PA200100959 A DKPA200100959 A DK PA200100959A DK 200100959 A DK200100959 A DK 200100959A
Authority
DK
Denmark
Prior art keywords
formula
propyl magnesium
preparation
citalopram
dimethylamino
Prior art date
Application number
DK200100959A
Other languages
English (en)
Inventor
Rock Michael Harold
Hans Petersen
Peter Ellegaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority to DK200100959A priority Critical patent/DK200100959A/da
Publication of DK200100959A publication Critical patent/DK200100959A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

KRAV
1. En fremgangsmåde til fremstilling af citalopram omfattende reaktion af en forbindelse med formlen IV
Figure DK200100959AD00031
hvori R er C,.6 alkyl, acyl, Cu alkylsulfonyl eller arylsulfonyl, roed 3-(N,N-dimethyIarmiio)-propylmagnesiumhalid, fortrinsvis 3-(N,N-dimethylamirto)propylniagiicsiuinchlorid for at opnå citalopram
Figure DK200100959AD00032
som isoleres som basen eller et farmaceutisk acceptabelt salt deraf. 1. Fremgangsmåden ifølge krav 1 kendetegnet ved, at mellemproduktet med formlen IV fremstilles ved oxidation af den tilsvarende forbindelse med formlen V:
Figure DK200100959AD00033
hvori R er defineret som i krav 1.
3. Fremgangsmåden ifølge krav 2 kendetegnet ved, at forbindelsen med formlen V fremstilles ved beskyttelse af hydroxymetbylalkoholen af (4-cyano-2-hydroxymethylphenylX4-fluoiphenyl)methanol af formel VI
Figure DK200100959AD00041
4. Fremgangsmåden ifølge krav 1 kendetegnet ved, at mellemproduktet med formlen IV fremstilles ved oxidadv spaltning af den tilsvarende forbindelse med formlen VH:
Figure DK200100959AD00042
hvori R er som defineret som i krav 1. 5. Fremgangsmåden ifølge krav 4 kendetegnet ved at den oxidative spaltning af forbindelen med formlen VII sker ved oxidation fortrinsvis med af MnOf (permanganater), eller ozon, RuClj, OsO«. 6. Fremgangsmåden ifølge et hvilket som helst af kravene 4 - 5 kendetegnet ved, at mellemproduktalkenen med fonnlen ΥΠ fremstilles ved beskyttelse og dehydrering af den tilsvarende forbindelse med formlen ΙΠ:
Figure DK200100959AD00051
hvori forbindelsen med formlen III er R-enantiomcren. 7. Fremgangsmåden ifølge krav I kendetegnet ved, at mellemproduktet roed formlen IV fremstilles ved reaktion af 5-cyanophthalid med 4-fluorphenylmagnesiumhalid, fortrinsvis 4-iluorphenylmagnesiumbromid efterfulgt af reaktion med R-X for at fremstille kctonforbindelsen med formlen IV, hvori R er som defineret i krav 1 og X er en leavjng-grnppe, fortrinsvis er R-X pivaloylchlorid, 3,5-dimethoxybenzoylcWorid, methyliodid, cthylbromid, tosylchlorid, Me2S04 eller MeS02Cl. 8. Fremgangsmåde til fremstilling af den racemiske forbindelse med formlen III omfattende de følgende trin
a) afbeskyttelse af en forbindelse med formlen IV
Figure DK200100959AD00052
hvori R er som defineret i krav 1
b) reaktion af den opnåede forbindelse med formlen VIII
Figure DK200100959AD00061
med 3-(N,N-dimefoylamino)propylmagnesiuinhaUd, fortrinsvis 3-(N,N-dimethyI-amino)propylmagnesiumchlorid, for at fremstille den racemiske forbindelse med formlen m
Figure DK200100959AD00062
9. Fremgangsmåden ifølge et hvilket som helst af kravene 1-8 hvori R er acyl, fortrinsvis pivaloyl, acetyl eller eventuelt substitueret benzoyt. JO. En forbindelse med formlen IV:
Figure DK200100959AD00063
hvori R er C,.« alkyl, acyl, CM alkylsulfonyl eller arylsulfonyl, fortrinsvis pivaloyl, acetyl eller eventuelt substitueret benzoyl. 11. En antidepressiv farmaceutisk komposition omfattende citalopram fremstillet ved fremgangsmåden ifølge et hvilket om helst af kravene 1-9. 12. Anvendelse af et mellemprodukt ifølge krav 10 til fremstilling af citalopram eller S-citalopram.
DK200100959A 1999-10-25 2001-06-20 Fremgangsmåde til fremstilling af citalopram DK200100959A (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200100959A DK200100959A (da) 1999-10-25 2001-06-20 Fremgangsmåde til fremstilling af citalopram

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH02004/01A CH692298A5 (de) 1999-10-25 1999-10-25 Verfahren zur Herstellung von Zwischenstufen für die Citalopramsynthese sowie zur Herstellung von Escitalopram.
ES200150056A ES2169709A1 (es) 1999-10-25 1999-10-25 Metodo para la preparacion de citalopram
PCT/DK1999/000581 WO2000012044A2 (en) 1999-10-25 1999-10-25 Method for the preparation of citalopram
CH01179/01A CH692421A5 (de) 1999-10-25 1999-10-25 Verfahren zur Herstellung von Citalopram.
DK200100959A DK200100959A (da) 1999-10-25 2001-06-20 Fremgangsmåde til fremstilling af citalopram

Publications (1)

Publication Number Publication Date
DK200100959A true DK200100959A (da) 2001-07-11

Family

ID=27429871

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200100959A DK200100959A (da) 1999-10-25 2001-06-20 Fremgangsmåde til fremstilling af citalopram

Country Status (11)

Country Link
US (1) US6407267B1 (da)
EP (1) EP1228056B1 (da)
AU (1) AU742554B2 (da)
CH (2) CH692298A5 (da)
DK (1) DK200100959A (da)
ES (2) ES2169709A1 (da)
GB (1) GB2360281B (da)
NO (1) NO325185B1 (da)
SK (1) SK287139B6 (da)
TR (1) TR200101874T1 (da)
WO (1) WO2000012044A2 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA002977B1 (ru) 1998-10-20 2002-12-26 Х.Лундбекк А/С Способ получения циталопрама
PT1140886E (pt) 1998-12-23 2003-08-29 Lundbeck & Co As H Metodo para a preparacao de 5- cianoftalida
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
ES2195554T5 (es) 1999-04-14 2010-02-02 H. Lundbeck A/S Metodo para la preparacion de citalopram.
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ES2169709A1 (es) 1999-10-25 2002-07-01 Lundbeck & Co As H Metodo para la preparacion de citalopram
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
AU778751B2 (en) 1999-12-28 2004-12-16 H. Lundbeck A/S Method for the preparation of citalopram
ATE253568T1 (de) 1999-12-30 2003-11-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
WO2001051477A1 (en) 2000-01-14 2001-07-19 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
FR2805812A1 (fr) 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
JP2003527385A (ja) 2000-03-13 2003-09-16 ハー・ルンドベック・アクチエゼルスカベット 5−置換された1−(4−フルオロフェニル)−1,3−ジヒドロイソベンゾフランの段階的アルキル化法
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
PL360110A1 (en) 2000-03-13 2004-09-06 H.Lundbeck A/S Method for the preparation of citalopram
PL360107A1 (en) 2000-03-14 2004-09-06 H.Lundbeck A/S Method for the preparation of citalopram
CZ20023406A3 (cs) * 2000-03-16 2003-01-15 H. Lundbeck A/S Způsob výroby 5-kyano-1-(4-fluorfenyl)-1,3-dihydroisobenzofuranu
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
IL144817A0 (en) 2000-08-18 2002-06-30 Lundbeck & Co As H Method for the preparation of citalopram
CA2360303C (en) 2000-12-22 2003-08-12 Marco Villa Process for the preparation of pure citalopram
EP1181272B1 (en) 2000-12-28 2002-08-28 H. Lundbeck A/S Process for the preparation of pure citalopram
CA2435925A1 (en) 2001-01-30 2002-08-08 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
FI20021421A0 (fi) * 2002-07-30 2002-07-30 Orion Corp Fermion Valmistusmenetelmä
PE20040991A1 (es) * 2002-08-12 2004-12-27 Lundbeck & Co As H Separacion de intermediarios para la preparacion de escitalopram
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
CN100569765C (zh) 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
GB0601286D0 (en) * 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
US9339500B2 (en) * 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143702A (da) 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DE19626659A1 (de) 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
DK1015416T3 (da) 1997-07-08 2001-11-05 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
JP3813820B2 (ja) 1997-11-11 2006-08-23 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
EA002977B1 (ru) 1998-10-20 2002-12-26 Х.Лундбекк А/С Способ получения циталопрама
PT1140886E (pt) 1998-12-23 2003-08-29 Lundbeck & Co As H Metodo para a preparacao de 5- cianoftalida
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
ES2195554T5 (es) 1999-04-14 2010-02-02 H. Lundbeck A/S Metodo para la preparacion de citalopram.
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ES2169709A1 (es) 1999-10-25 2002-07-01 Lundbeck & Co As H Metodo para la preparacion de citalopram
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
JP4025501B2 (ja) 2000-03-03 2007-12-19 株式会社ソニー・コンピュータエンタテインメント 楽音発生装置
CA2360303C (en) 2000-12-22 2003-08-12 Marco Villa Process for the preparation of pure citalopram
EP1181272B1 (en) 2000-12-28 2002-08-28 H. Lundbeck A/S Process for the preparation of pure citalopram

Also Published As

Publication number Publication date
US20020035277A1 (en) 2002-03-21
SK287139B6 (sk) 2010-01-07
CH692298A5 (de) 2002-04-30
TR200101874T1 (tr) 2002-02-21
AU6326599A (en) 2000-03-21
NO325185B1 (no) 2008-02-11
ES2169709A1 (es) 2002-07-01
GB2360281A (en) 2001-09-19
CH692421A5 (de) 2002-06-14
GB2360281B (en) 2002-01-16
SK9242001A3 (en) 2001-12-03
GB0115030D0 (en) 2001-08-08
WO2000012044A3 (en) 2000-08-03
ES2229774T3 (es) 2005-04-16
NO20013185L (no) 2001-08-24
US6407267B1 (en) 2002-06-18
AU742554B2 (en) 2002-01-03
WO2000012044A2 (en) 2000-03-09
NO20013185D0 (no) 2001-06-25
EP1228056B1 (en) 2004-09-22
EP1228056A2 (en) 2002-08-07

Similar Documents

Publication Publication Date Title
DK200100959A (da) Fremgangsmåde til fremstilling af citalopram
JP2700024B2 (ja) α−アリール飽和脂肪族カルボン酸
CZ291440B6 (cs) Způsob výroby citalopramu
CA2791482A1 (fr) Derives de cetobenzofurane ainsi que leur procede de synthese et les intermediaires
MXPA01013336A (es) Proceso para la preparacion de citalopram puro.
Schultz The asymmetric Birch reduction and reduction–alkylation strategies for synthesis of natural products
JP2003012663A (ja) シタロプラムの製造方法
HUP0200169A2 (en) Method for the preparation of citalopram
US20060009515A1 (en) Process and intermediates for preparing escitalopram
CN112358432B (zh) 一种吲哚类衍生物的合成方法
FR2752839A1 (fr) Derives de benzofurane, leur preparation et leur application en therapeutique
JPH0592963A (ja) Paf拮抗剤として有用な2,5−ジアリールテトラヒドロフラン類及びその類縁体の製造方法
JPH07330725A (ja) インドリン誘導体
FR2752840A1 (fr) Derives de benzothiophene, leur preparation et leur application en therapeutique
JP2000169407A (ja) 3−ブテン−1−オール誘導体の製造方法
JP2011528012A (ja) ラメルテオンの調製における中間体としての6,7−ジヒドロ−1h−インデノ[5,4−b]フラン−8(2h)−オンの合成
WO2000035898A1 (fr) DERIVES D'HYDRONAPHTO[2,3-c]FURANE ET PROCEDE DE PREPARATION DESDITS DERIVES
JP3365764B2 (ja) シタロプラムの製造方法
US6252092B1 (en) Process for synthesis of 5-alkylbenzodioxoles
JPH0374674B2 (da)
CS271479B2 (en) Method of alpha-hydroxy-bicyclo/3,3,0/octane's derivatives production
JPH01216951A (ja) 4−アシルオキシ−1−(2−置換エトキシ)ベンゼン類及びその合成中間体並びにそれらの製造方法
JPS6377837A (ja) シクロペンテノン誘導体の製造法
FR2752735A1 (fr) Utilisation de derives de benzofurane pour obtenir un medicament destine au traitement de l'insuffisance veineuse et de l'ulcere veineux
JPH05262674A (ja) フロログルシン型フェノールのベンジルエーテルの合成法

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment